ORIC Pharmaceuticals Names Pratik Multani Chief Medical Officer

Pratik Multani has been appointed chief medical officer of South San Francisco, CA-based ORIC Pharmaceuticals. Multani was most recently chief medical officer of Ignyta, a San Diego biotech that was acquired by Roche in a $1.7 billion deal last year. ORIC—which stands for “overcoming resistance in cancer”—develops drugs for cancers that have become resistant to earlier treatments. The company is preparing to bring lead drug candidate ORIC-101 into clinical trials as a treatment for solid tumors.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.